OCR Announces Settlement with Clinical Lab for Alleged HIPAA Violations

Robinson+Cole Data Privacy + Security Insider
Contact

The Office for Civil Rights (OCR) this week announced a settlement with Peachstate Health Management LLC (aka AEON Clinical Laboratories) following a compliance review that uncovered alleged violations of HIPAA.

The settlement includes a $25,000 payment to OCR by Peachstate, a corrective action plan, and three years of monitoring by OCR.

OCR initiated a compliance review of Peachstate in December 2017 to determine its compliance with HIPAA following a report of a data breach by the U.S. Department of Veterans Affairs.  The notification alleged that the data breach was caused by the VA’s vendor, which was subsequently acquired by Peachstate.

According to OCR’s press release, “OCR’s investigation found systemic noncompliance with the HIPAA Security Rule, including failures to conduct an enterprise-wide risk analysis, implement risk management and audit controls, and maintain documentation of HIPAA Security Rule policies and procedures.”

OCR further stated, “This settlement reiterates OCR’s commitment to ensuring compliance with rules that protect the privacy and security of protected health information.”

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Robinson+Cole Data Privacy + Security Insider | Attorney Advertising

Written by:

Robinson+Cole Data Privacy + Security Insider
Contact
more
less

Robinson+Cole Data Privacy + Security Insider on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.